The Activator I and II solutions provide the substrate for the ELISPOT assay based on silver staining and should be used in conjunction with GABA conjugate (CT351). Prior to use and as final step in the ELISPOT procedure, the solutions should be mixed (1:1) and added to the wells of the ELISPOT plate. The substrate will produce a microscopally black and visually yellow/brown spot. Upon ordering, you will receive one vial containing 9.5 ml Activator I and one vial containing 9.5 ml Activator II for 480 ELISPOT determinations.
References list
- Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination.
- Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.
- Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.
- Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor.
u-cytech Biosciences公司成立于1999与乌特列支大学合作的生物科技公司和位于乌得勒支的荷兰（欧洲）。该家族企业以开放的政策和众多忠实的顾客从事细胞因子生物学的基础研究和应用研究，致力于在ELISA和T、B细胞的ELISPOT检测而设计的个别蛋白质分泌细胞的体外检测。此外，我们开发的“房子”一个广泛的高度特异的单克隆抗体和多克隆抗体的蛋白质包括不同的物种形成了我们高度敏感的检测的基础上（ELISA、ELISPOT、FluoroSpot）。
本网站将在规定时间内给予删除等相关处理。
